ストックスクリーナーアプリを入手
12.33
2.49%
0.30
プレマーケット:
12.44
0.11
+0.89%
前日終値:
$12.03
開ける：
$12.13
24時間の取引高:
1.17M
Relative Volume:
0.41
時価総額：
$1.27B
収益：
$187.64M
当期純損益:
$-95.00M
株価収益率:
-12.98
EPS:
-0.95
ネットキャッシュフロー:
$-69.02M
1週間 パフォーマンス:
+1.82%
1か月 パフォーマンス:
+30.48%
6か月 パフォーマンス:
+70.54%
1年 パフォーマンス:
-3.45%
1日の値動き範囲:
$12.05
$12.50
1週間の範囲:
$11.60
$13.20
52週間の値動き範囲:
$5.635
$13.53
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
名前
Day One Biopharmaceuticals Inc
セクター
電話
650 484-0899
住所
1800 SIERRA POINT PARKWAY, SUITE 200, BRISBANE
DAWN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
12.33 | 1.24B | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-13 | 再開されました | TD Cowen | Buy |
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2024-10-09 | 繰り返されました | Needham | Buy |
| 2024-08-01 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-04-24 | 繰り返されました | Needham | Buy |
| 2023-04-25 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-08 | 開始されました | CapitalOne | Overweight |
| 2023-02-03 | 開始されました | Oppenheimer | Perform |
| 2022-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-14 | 開始されました | Needham | Buy |
| 2022-12-05 | 開始されました | Goldman | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
すべてを表示
Day One Biopharmaceuticals Inc (DAWN) 最新ニュース
Best Momentum Stocks to Buy for January 27th - Yahoo Finance
New Strong Buy Stocks for January 27th - Yahoo Finance Singapore
Is Day One Biopharmaceuticals Inc a top pick in the sectorQuarterly Profit Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
AIGH Capital Management LLC Makes New Investment in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A Biotech with 90% Upside Potential - directorstalkinterviews.com
Will Day One Biopharmaceuticals Inc. stock go up in YEARJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru
Discipline and Rules-Based Execution in DAWN Response - Stock Traders Daily
'Follow The Money,' Not The Tariff Noise, Says Expert, Spotlights This New S&P Data Center Cooling Stock Among Top Picks - Sahm
Optimistic Investors Push Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Up 31% But Growth Is Lacking - simplywall.st
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Up 7.6%Time to Buy? - MarketBeat
Day One Biopharmaceuticals Sees Unusually Large Options Volume (NASDAQ:DAWN) - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Up 19.2% in December - MarketBeat
H.C. Wainwright Maintains Buy Rating on Day One Biopharmaceuticals (DAWN), Keeps PT - MSN
Earnings Beat: How does Day One Biopharmaceuticals Inc compare to its peersJuly 2025 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn
First Week of March 20th Options Trading For Day One Biopharmaceuticals (DAWN) - Nasdaq
Growth Recap: How does Day One Biopharmaceuticals Inc compare to its peers2025 Earnings Impact & Daily Chart Pattern Signals - baoquankhu1.vn
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet - sharewise.com
Day One Biopharmaceuticals (DAWN) Is Up 11.7% After Strong OJEMDA 2025 Sales And 2026 OutlookHas The Bull Case Changed? - Sahm
Update Report: Is Day One Biopharmaceuticals Inc a top pick in the sectorQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Retail Trends: Can Day One Biopharmaceuticals Inc generate free cash flow2025 Big Picture & Fast Entry Momentum Alerts - baoquankhu1.vn
Rally Mode: How geopolitical tensions affect Day One Biopharmaceuticals Inc stockLayoff News & Daily Chart Pattern Signals - Bộ Nội Vụ
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Down 10.1%What's Next? - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Earns Buy Rating from Analysts at TD Cowen - MarketBeat
Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains? - Yahoo Finance
A Look At Day One Biopharmaceuticals (DAWN) Valuation After Strong OJEMDA Revenue And 2026 Outlook Updates - Yahoo Finance
Day One Biopharmaceuticals stock initiated with Buy rating at TD Cowen - Investing.com Canada
DAWN: OJEMDA's growth and new pipeline assets set the stage for significant revenue expansion in 2026 - TradingView — Track All Markets
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance - Sahm
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap UpTime to Buy? - MarketBeat
Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday - Benzinga
Day One Biopharmaceuticals stock soars after strong 2025 revenue forecast By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Day One Biopharmaceuticals Reports 172% Year-over-Year Growth in 2025 Net Product Revenue, Projects 2026 Revenue Between $225 Million and $250 Million - Quiver Quantitative
Day One says Ojemda 2026 U.S. net product revenue projected to be $225$250 million - marketscreener.com
Day One Announces Preliminary 2025 OJEMDA Net Product Revenue And Provides 2026 Net Product Revenue Guidance - 富途资讯
Cancer drug OJEMDA sales jump 172% in 2025 as Day One sets 2026 target - Stock Titan
Behavioral Patterns of DAWN and Institutional Flows - Stock Traders Daily
Day One Biopharmaceuticals Stock Pre-Market (+5.4%) : Market Digests Mersana Acquisition - Trefis
How to contact the Daily Bulletin - FinancialContent
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Day One Biopharmaceuticals, Inc.Common Stock (NQ: DAWN - FinancialContent
Will Day One Biopharmaceuticals Inc. stock benefit from automationQuarterly Market Summary & Reliable Momentum Entry Alerts - ulpravda.ru
Trading Action: Is Day One Biopharmaceuticals Inc. stock a good choice for value investorsWall Street Watch & Technical Buy Zone Confirmation - Улправда
How The Day One Deal Is Reshaping The Story For Mersana Therapeutics (MRSN) - Yahoo Finance
Day One concludes Mersana Therapeutics acquisition - Yahoo Finance
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Up 11.2%Here's What Happened - MarketBeat
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics By Investing.com - Investing.com Nigeria
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics - Investing.com
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics - TipRanks
Day One Biopharmaceuticals Inc (DAWN) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):